Evonik Industries responds to strong demand for polyamide 12 by expanding laurolactam in Marl
Essen, Germany-based Evonik Industries plans to expand laurolactam production capacities significantly at its Marl site. The extra capacities are expected to be available by the fourth quarter of 2010. Laurolactam is the starting material for the polymer polyamide 12.
“We’re recording persistently high demand for our polyamide business,” explains Dr. Joachim Leluschko, the head of Evonik’s High Performance Polymers Business Line. “That’s why we’ll be further substantial expanding capacities for laurolactam production in Marl.” The move sees Evonik consolidating its globally leading position on the market for polyamide 12 and acting as a reliable partner to secure supplies to its customers into the future.
The High Performance Polymers Business Line markets polyamide 12 as VESTAMID®, an engineering material, and VESTOSINT® powder. It supplies these products to all key markets. At the core, what this business line does is manufacture products specially geared to demand and customer needs. A global sales network, service centers in Europe, America, and Asia, not to mention comprehensive technical service, all serve to ensure the global availability of its high-performance polymers, semi-finished products, and professional technical support.
Categories
Investments
Chemical substances
Countries
Companies
Latest news
Hycamite’s technology to decarbonize shipping awarded AiP by industry leader DNV
Kokkola Industrial Park →Hycamite’s proprietary Thermo-Catalytic Decomposition (TCD) technology offers a new approach to producing clean hydrogen by breaking down methane, the primary component of liquefied natural gas (LN...
Clariant catalysts will power the Ecoplanta: Europe's first waste-to-methanol plant
Chemmed Cluster Tarragona →Repsol is building Europe’s first plant to produce renewable methanol from urban waste The facility will use Enerkem gasification technology to produce 240 KTA of methanol Clariant will supply cata...
Lilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide
Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain
Ports of Duisburg and Rotterdam advance energy transition together
Port of Rotterdam →With this LoI, the two major European logistics hubs reinforce their goal of jointly developing sustainable transport corridors via waterways as well as future-oriented initiatives for the energy t...
